ClinicalTrials.gg
RecruitingNCT07842250BBTI AppUpdated Sep 25, 2026

The Effect of Nurse-Led Mobile APP-based Brief Behavioral Therapy for Insomnia in Older Adults

An interventional study of Nurse-Led Mobile BBTI and Face-to-Face BBTI in Insomnia, sponsored by Taipei Medical University. Recruiting at 1 site in Taiwan. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-09-25.

Sponsored by Taipei Medical University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Aug 2026; still recruiting 2 months later.
Updated Sep 25, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-18

Among 20 studies in Sleep Initiation and Maintenance Disorders by Taipei Medical University — 10 open to participants now, 10 under way, none of them phase 3. Sleep Initiation and Maintenance Disorders · Taipei Medical University.

Planned enrollment
9th of 18
60 · median 60
Started
2026
with 3 others
No phase
18 of 20
10 open now
Registered
19th of 20
by date

Among the 20 studies in Sleep Initiation and Maintenance Disorders by Taipei Medical University, this one is the 9th largest by planned enrollment of the 18 interventional ones that give a count, is one of 4 that started in 2026, is one of 18 with no phase, and was the 19th registered.

Sleep Initiation and Maintenance Disorders

2,732 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 731 are open to participants now.

Browse Sleep Initiation and Maintenance Disorders studies →

Open to participants now

10 of the 20 studies in Sleep Initiation and Maintenance Disorders by Taipei Medical University are open now, in 2 countries. Recruiting first, the newest first:

4 more — sign in →

By country, each count listing its studies:

All 10 open studies →

Where they have run

Who these studies take

Of the 390 Sleep Initiation and Maintenance Disorders studies recruiting now, 153 (39%) set no upper age limit and 207 (53%) stop at 75 or younger; 59 take children under 18; 109 take healthy volunteers.

This study: 65 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 20 studies in Sleep Initiation and Maintenance Disorders by Taipei Medical University, or all of them as a file.
02

Study summary

Background: Insomnia affects 20%-30% of older adults and is linked to increased fall risk, cognitive decline, and cardiovascular disease. While cognitive behavioral therapy for insomnia (CBT-I) is the first-line treatment, its length and limited workforce restrict implementation. Brief Behavioral Treatment for Insomnia (BBTI), a four-week intervention, offers a simplified alternative. However, digital-only approaches may be challenging for older adults, making nurse-supported digital BBTI a potential solution.

Objective and Methods: This study evaluates the effectiveness of a nurse-guided, app-based BBTI. A three-arm randomized controlled trial will recruit 60 adults aged ≥65 with ISI ≥15, assigned to a nurse-guided app group, face-to-face treatment, or sleep education. The app group receives a four-week intervention with nurse follow-up. The face-to-face treatment group received weekly nurse-delivered BBTI for four weeks, while the sleep education group received a sleep education booklet.

Evaluation: The primary outcome is ISI, with secondary measures including PSQI, ESS, DASS-21, wearable sleep data, and user satisfaction. Data will be analyzed using LMM. This study is expected to improve treatment accessibility and support evidence-based insomnia care for older adults.

03

Conditions studied

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 65 years or older.
  • An Insomnia Severity Index (ISI) score of 15 or higher, with the presence of insomnia-related symptoms such as difficulty initiating sleep, frequent nocturnal awakenings, or early morning awakening.
  • Conscious and able to understand the study information.
  • Ownership of a smartphone.
  • Ability to operate the application and complete online questionnaires independently or with assistance from research staff or family.

Exclusion criteria

Exclusion Criteria:

  • Presence of severe psychiatric disorders with an unstable clinical condition.
  • Diagnosed or suspected moderate to severe obstructive sleep apnea that has not been treated.
  • Adjustment of sleep-related medication dosage within the past four weeks.
  • Engagement in shift work or night work.
  • Participants with acute cardiopulmonary diseases.
  • Participants reporting a pain intensity score of ≥ 5 (on a 0-10 numeric rating scale) that interferes with sleep.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Nurse-Led Mobile BBTI

    Participants in this group will receive a 4-week brief behavioral treatment for insomnia (BBTI) delivered through a mobile application with nurse guidance. The intervention includes sleep diary monitoring, stimulus control, sleep restriction, fixed wake-time recommendations, relaxation strategies, sleep education, and individualized feedback based on participants' sleep patterns. Nurses will provide regular guidance and follow-up throughout the intervention period.

    Behavioral: Nurse-Led Mobile BBTI

  • Active comparator
    Face-to-Face BBTI

    Participants in this group will receive a 4-week brief behavioral treatment for insomnia (BBTI) delivered by a trained nurse. The intervention includes sleep diary review, stimulus control, sleep restriction, fixed wake-time recommendations, relaxation strategies, and sleep education. Four sessions will be provided during the intervention period, including in-person sessions and telephone follow-up, with individualized adjustment of behavioral recommendations according to participants' sleep patterns.

    Behavioral: Face-to-Face BBTI

  • Active comparator
    Sleep Education

    Participants in this group will receive sleep education during the 4-week study period. Educational materials will provide general information about sleep, healthy sleep habits, and factors that may affect sleep. Participants will receive regular follow-up during the study period but will not receive active behavioral components of BBTI, such as stimulus control or sleep restriction.

    Behavioral: Sleep Education

Interventions

  • BehavioralNurse-Led Mobile BBTI

    Participants in this group will receive a 4-week Brief Behavioral Therapy for Insomnia (BBTI) intervention delivered through a mobile application with nurse guidance. The intervention includes sleep diary monitoring, stimulus control, sleep restriction, fixed wake-time recommendations, relaxation strategies, sleep education, and individualized feedback based on participants' sleep patterns. Nurses will provide regular guidance and follow-up throughout the intervention period.

  • BehavioralFace-to-Face BBTI

    Participants in this group will receive a 4-week Brief Behavioral Therapy for Insomnia (BBTI) intervention delivered by a trained nurse. The intervention includes sleep diary review, stimulus control, sleep restriction, fixed wake-time recommendations, relaxation strategies, and sleep education. Four sessions will be provided during the intervention period, including in-person sessions and telephone follow-up, with individualized adjustment of behavioral recommendations according to participants' sleep patterns.

  • BehavioralSleep Education

    Participants in this group will receive sleep education during the 4-week study period. Educational materials will provide general information about sleep, healthy sleep habits, and factors that may affect sleep. Participants will receive regular follow-up throughout the study period but will not receive active behavioral components of BBTI, such as stimulus control or sleep restriction.

06

What researchers measure

Primary outcomes

  1. Insomnia Severity Index (ISI)

    Insomnia severity will be assessed using the Chinese version of the Insomnia Severity Index (C-ISI). The ISI consists of 7 items assessing the severity and impact of insomnia symptoms. Each item is rated from 0 to 4, yielding a total score ranging from 0 to 28, with higher scores indicating greater insomnia severity.

    Time frame: Baseline and immediately after the 4-week intervention and 1-month follow up

Secondary outcomes

  1. Pittsburgh Sleep Quality Index (PSQI) Score

    Subjective sleep quality will be assessed using the Chinese version of the Pittsburgh Sleep Quality Index (CPSQI). The questionnaire evaluates multiple dimensions of sleep quality over the previous month. The global score ranges from 0 to 21, with higher scores indicating poorer sleep quality.

    Time frame: Baseline and immediately after the 4-week intervention and 1-month follow up

  2. Epworth Sleepiness Scale (ESS) Score

    Daytime sleepiness will be assessed using the Chinese version of the Epworth Sleepiness Scale (CESS). The scale consists of 8 items assessing the likelihood of dozing in common daily situations. Total scores range from 0 to 24, with higher scores indicating greater daytime sleepiness.

    Time frame: Baseline and immediately after the 4-week intervention and 1-month follow up

  3. Depression, Anxiety and Stress Scale-21 (DASS-21) Scores

    Psychological symptoms will be assessed using the 21-item Depression, Anxiety and Stress Scale (DASS-21). The instrument includes three subscales assessing depression, anxiety, and stress symptoms, with higher scores indicating greater symptom severity.

    Time frame: Baseline and immediately after the 4-week intervention and 1-month follow up

  4. Change in Sleep Onset Latency (SOL)

    Sleep onset latency will be derived from daily sleep diaries and defined as the self-reported time from attempting to sleep to sleep onset.

    Time frame: Baseline and during the 4-week intervention period and 1-month follow up

  5. Change in Wake After Sleep Onset (WASO)

    Wake after sleep onset will be derived from daily sleep diaries and defined as the total self-reported time spent awake after initial sleep onset and before final awakening.

    Time frame: Baseline, during the 4-week intervention, and 1-month follow-up.

  6. Change in Total Sleep Time (TST)

    Total sleep time will be derived from daily sleep diaries and defined as the total self-reported amount of time spent asleep during the main sleep period.

    Time frame: Baseline, during the 4-week intervention, and 1-month follow-up.

  7. Change in Time in Bed (TIB)

    Time in bed will be derived from daily sleep diaries and defined as the interval between bedtime and getting out of bed.

    Time frame: Baseline, during the 4-week intervention, and 1-month follow-up.

  8. Change in Sleep Efficiency (SE)

    Sleep efficiency will be derived from daily sleep diaries and calculated as total sleep time divided by time in bed and multiplied by 100.

    Time frame: Baseline, during the 4-week intervention, and 1-month follow-up.

  9. Change in Actigraphy-Derived Total Sleep Time(TST-Actigraphy)

    Objective total sleep time will be assessed using a wrist-worn actigraphy device and expressed as the estimated total amount of time spent asleep.

    Time frame: Baseline and during the 4-week intervention period and 1-month follow up

  10. Change in Actigraphy-Derived Sleep Onset Latency(SOL-Actigraphy)

    Objective sleep onset latency will be assessed using a wrist-worn actigraphy device and defined as the estimated time from attempting to sleep to sleep onset.

    Time frame: Baseline, during the 4-week intervention, and 1-month follow-up.

  11. Change in Actigraphy-Derived Wake After Sleep Onset(WASO-Actigraphy)

    Objective wake after sleep onset will be assessed using a wrist-worn actigraphy device and defined as the estimated amount of time spent awake after initial sleep onset.

    Time frame: Baseline, during the 4-week intervention, and 1-month follow-up.

  12. Change in Actigraphy-Derived Time in Bed (TIB-Actigraphy)

    Time in bed (TIB) will be derived from wrist-worn actigraphy data and defined as the duration of the designated nocturnal sleep interval. TIB corresponds to the "Duration" variable in the actigraphy output and will be expressed in minutes.

    Time frame: Baseline, during the 4-week intervention, and 1-month follow-up.

  13. Change in Actigraphy-Derived Sleep Efficiency(SE-Actigraphy)

    Objective sleep efficiency will be assessed using a wrist-worn actigraphy device and expressed as the percentage of time in bed spent asleep.

    Time frame: Baseline, during the 4-week intervention, and 1-month follow-up.

  14. Intervention Satisfaction and Feasibility

    Participants' satisfaction with and perceived feasibility of the intervention will be assessed using a study-specific questionnaire evaluating aspects such as ease of use, acceptability, willingness to continue using the intervention, and perceived usefulness. Higher scores indicate greater satisfaction or perceived feasibility.

    Time frame: Participants assigned to the nurse-led mobile BBTI group will complete after the 4-week intervention.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2026 (actual). Primary completion is estimated for Jul 2027, 11 months after the start.

Of 1,213 non-industry interventional studies with no phase under Sleep Initiation and Maintenance Disorders, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 35. This study's planned 11 months is below that.

Counting every sponsor, half of 1,291 studies reached it within 15 months; a quarter within 6 and three quarters within 34.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 10, 2026
First posted
Sep 25, 2026
StartActual
Aug 31, 2026
Primary completionEst.
Jul 31, 2027
CompletionEst.
Aug 31, 2027
Last update
Sep 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Sep 25, 2026
Show all 1 update
  1. Sep 25, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07842250
Responsible party
Sponsor
First posted
Sep 25, 2026
Start date
Aug 31, 2026
Primary completion
Jul 31, 2027 (estimated)
Completion
Aug 31, 2027 (estimated)
Last update
Sep 25, 2026

Study contacts

YuFang Chang
Contact
m432114001@tmu.edu.tw
+886-906-821-933

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion